Table 2

Clinical Events at 14-Day Follow-Up

Stress Test (n = 496)Controls(n = 499)
Clinical stent thrombosis, no. (%)
 Acute thrombosis (≤12 h)1 (0.2)1 (0.2)
 Subacute thrombosis (>12 h)4 (0.8)4 (0.8)
 Any thrombosis5 (1.0)5 (1.0)
Access site complications, no. (%)
 Pseudoaneurysm2 (0.4)3 (0.6)
 Arteriovenous fistula01 (0.2)
 Deep vein thrombosis/pulmonary embolism1 (0.2)1 (0.2)
 Surgical repair1 (0.2)2 (0.4)
 Blood transfusions01 (0.2)
 Hematoma17 (3.4)21 (4.3)
 Any access site complication20 (4.0)26 (5.2)

Hematoma was defined as femoral bleeding requiring prolonged or repeat compressive measures to achieve hemostasis, prolonged hospitalization, or surgical revision. The p value is nonsignificant for all comparisons.